Key Events This Week
15 Jun: Golden Cross formation signals potential bullish breakout
16 Jun: Technical momentum shifts to bullish amid mixed market returns
19 Jun: Week closes at Rs.797.10, up 3.65% for the week
Jul 10, 02:14 PM
BSE+NSE Vol: 17.63 k

Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators reveal a nuanced picture that investors must carefully analyse amid broader market trends.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend. Despite a recent day decline of 2.10%, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from Bollinger Bands and on-balance volume. This article analyses the evolving technical landscape and what it means for investors navigating this volatile stock.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s price action and technical indicators reveal a cautiously optimistic outlook tempered by underlying weaknesses.
Read full news article
15 Jun: Golden Cross formation signals potential bullish breakout
16 Jun: Technical momentum shifts to bullish amid mixed market returns
19 Jun: Week closes at Rs.797.10, up 3.65% for the week

Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend. Despite a modest day decline of 1.01%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid broader market dynamics.
Read full news article
The 50-day moving average has crossed above the 200-day moving average for Astec Lifesciences Ltd, signalling a golden cross on 15 Jun 2026. Yet, the stock declined 1.01% on the same day, and the monthly technical indicators present a nuanced picture. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.
Read full news article